Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga ·  Jun 11 02:10

Shares ofSkye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and has discontinued the program.

Skye Bioscience shares tumbled 18.9% to $8.87 on Monday.

Here are some other stocks moving in today's mid-day session.


  • Big Tree Cloud Holdings Limited(NASDAQ:DSY) shares jumped 123% to $4.3001 following the completion of the company's business combination with Plutonian Acquisition Corp. and amid continued volatility following its Nasdaq debut last week.
  • KWESST Micro Systems Inc. (NASDAQ:KWE) gained 79.8% to $0.7082 after the company was awarded...
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment